Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-05-27
1989-09-05
Ore, Dale R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
424DIG1, 424DIG2, 424DIG4, 424 70, 424 72, 514774, A61K 706, A61K 748, A61K 750
Patent
active
048639508
ABSTRACT:
Spherules of gelatin of the "soft" type containing cystin as activating substance, are used for stimulating and improving the keratinogenesis and reducing the seborrhoea of the face and of the scalp, by effect of a synergic activity of the components.
REFERENCES:
patent: 2558065 (1951-06-01), Tice
patent: 3089823 (1963-05-01), Czarnocki
patent: 3395236 (1968-07-01), White
patent: 3574820 (1971-04-01), Johnson et al.
patent: 3653934 (1972-04-01), Rolle
patent: 3663687 (1972-05-01), Evans
patent: 3950542 (1976-04-01), Kalopissis et al.
patent: 4035492 (1977-07-01), Kalopissis et al.
patent: 4073898 (1978-02-01), Bouillon et al.
patent: 4139635 (1979-02-01), Kalopissis et al.
patent: 4151301 (1979-04-01), Kalopissis
patent: 4208402 (1980-06-01), Bore
Merck Index, 6th Edition, 1952, pp. 303 & 304.
Thompson Food Drug Administration Consumer, 2/1981, pp. 10 & 12.
LandOfFree
Medicinal formulation for promoting keratinogenesis and reducing does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicinal formulation for promoting keratinogenesis and reducing, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicinal formulation for promoting keratinogenesis and reducing will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-243811